Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment

Luca Rozzini1, Barbara Vicini Chilovi, Erik Bertoletti

  • 1Department of Neurology, University of Brescia, Italy. lrozzini@iol.it

Abstract

Insights

Mild cognitive impairment (MCI) with mild extrapyramidal signs (EPS) is linked to worse non-memory cognitive function and more neuropsychiatric issues. The severity of EPS correlates with executive function deficits and episodic memory.

Area of Science:

  • Neurology
  • Neuropsychology
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) can present with extrapyramidal signs (EPS).
  • EPS are associated with the severity and type of cognitive impairment.
  • The relationship between MCI and EPS requires further elucidation.

Purpose of the Study:

  • To analyze the correlation between EPS severity and cognitive functions in MCI patients.
  • To investigate the presence of EPS and associated neuro-psychiatric features in MCI.
  • To understand the link between mild parkinsonian signs and cognitive/behavioral patterns in MCI.

Main Methods:

  • Longitudinal study of 150 MCI outpatients.
  • Clinical assessment using Unified Parkinson Disease Rating Scale (UPDRS), Neuropsychiatric Inventory, and Tinetti Scale.
  • Standardized neuropsychological battery and definition of mild EPS based on UPDRS subscale (bradykinesia, rigidity, tremor).

Main Results:

  • 24% of MCI patients exhibited mild EPS.
  • MCI with mild EPS showed worse performance in global cognitive scores and non-memory domains (Alzheimer's Disease Assessment Scale).
  • EPS severity correlated with poorer executive functions and better episodic memory; increased anxiety, depression, apathy, and sleep disturbances were noted in MCI with mild EPS.

Conclusions:

  • MCI can be associated with mild parkinsonian signs.
  • The severity of these signs relates to cognitive impairment, particularly non-memory functions.
  • A distinct pattern of psycho-behavioral symptoms accompanies MCI with mild EPS.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...